Literature DB >> 33628471

High Prevalence of Toxoplasma gondii Infection in Type I Diabetic Patients.

Qasem Asgari1, Mohammad Hossein Motazedian1, Amir Khazanchin1, Davood Mehrabani2, Shahrbanou Naderi Shahabadi1.   

Abstract

BACKGROUND: Type I diabetes (TΙDM) is a genetic or autoimmune disorder, which may be stimulated by induced immune system components due to the underlying infectious diseases. This study was undertaken to find out any possible association between Toxoplasma gondii infection and TIDM.
MATERIALS AND METHODS: One hundred and eighty-two blood samples were taken from individuals who were referred to outpatient clinics in Shiraz city, Southern Iran, during a 6-month period. The age of type I diabetic subjects (n = 91) and the control group (n = 91) was identical, which were less than 30 years. The sera were examined for IgG and IgM antibodies by ELISA and correlated with epidemiological factors such as age, sex, and family history of diabetes.
RESULTS: Out of 91 diabetic patients, 54 (59.3%) were female and 37 (40.7%) were male. The highest frequency of diabetes belonged to 6-10- and 11-15-year groups (P = 0.17). Toxoplasma infection prevalence in diabetic and control groups was 28.6% and 7.7%, respectively (P = 0.001). A significantly positive family history of diabetes was observed between diabetic patients (31 cases, 34.1%) and the control group (3 cases, 3.3%) (P = 0.01). Interestingly, IgG positivity was seen in 13 cases (41.9%) of patients with positive family history of type I diabetes and 13 cases (21.7%) of subjects with no positive family history of type I diabetes (P = 0.04).
CONCLUSION: Our study showed a higher prevalence of Toxoplasma infection in type I diabetes patients. It is likely that the prevalence of TIDM decreases by increasing hygiene and preventing toxoplasmosis.
Copyright © 2021 Qasem Asgari et al.

Entities:  

Year:  2021        PMID: 33628471      PMCID: PMC7889393          DOI: 10.1155/2021/8881908

Source DB:  PubMed          Journal:  J Parasitol Res        ISSN: 2090-0023


  39 in total

1.  Toxoplasma gondii as a possible causative pathogen of type-1 diabetes mellitus: Evidence from case-control and experimental studies.

Authors:  Engy Victor Nassief Beshay; Samar A El-Refai; Mohamed A Helwa; Amany Fawzy Atia; Marwa Mohammed Dawoud
Journal:  Exp Parasitol       Date:  2018-04-05       Impact factor: 2.011

2.  Inhibition of 2C Coxsackie B Virus Protein to Decrease Pathogenicity of Diabetes Mellitus Type 1.

Authors:  Amina Amin; Muhammad A Rasheed; Rana A Diwan; Muhammad Shahid; Saddia Bano; Adnan Riaz; Muhammad N Iqbal; Muhammad W Sajid
Journal:  Curr Comput Aided Drug Des       Date:  2020       Impact factor: 1.606

Review 3.  Host immune responses to Toxoplasma gondii.

Authors:  Miwa Sasai; Ariel Pradipta; Masahiro Yamamoto
Journal:  Int Immunol       Date:  2018-03-10       Impact factor: 4.823

4.  The prevalence of diabetes in Rio de Janeiro, Brazil. The Cooperative Group for the Study of Diabetes Prevalence in Rio De Janeiro.

Authors:  J E Oliveira; A Milech; L J Franco
Journal:  Diabetes Care       Date:  1996-06       Impact factor: 19.112

5.  Seroprevalence of toxoplasmosis in the residents of Cheju island, Korea.

Authors:  H J Yang; K N Jin; Y K Park; S C Hong; J M Bae; S H Lee; H S Choi; H S Hwang; Y B Chung; N S Lee; H W Nam
Journal:  Korean J Parasitol       Date:  2000-06       Impact factor: 1.341

6.  Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.

Authors:  M von Herrath; A Holz
Journal:  J Autoimmun       Date:  1997-06       Impact factor: 7.094

7.  Cytokine profile in murine toxoplasmosis.

Authors:  Funda Dogruman-Al; Isil Fidan; Bekir Celebi; Emine Yesilyurt; Berna Erdal; Cahit Babur; Semra Kustimur
Journal:  Asian Pac J Trop Med       Date:  2011-01-15       Impact factor: 1.226

8.  Rapid-onset type 1 diabetes associated with cytomegalovirus infection and islet autoantibody synthesis.

Authors:  Keiichiro Osame; Yoshihiko Takahashi; Hirofumi Takasawa; Shigeru Watanabe; Miyako Kishimoto; Kazuki Yasuda; Yasushi Kaburagi; Koji Nakanishi; Hiroshi Kajio; Mitsuhiko Noda
Journal:  Intern Med       Date:  2007-06-15       Impact factor: 1.271

9.  Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran.

Authors:  Bahador Sarkari; Reza Shafiei; Mani Zare; Sattar Sohrabpour; Leila Kasraian
Journal:  J Infect Dev Ctries       Date:  2014-04-15       Impact factor: 0.968

Review 10.  Is chronic toxoplasmosis a risk factor for diabetes mellitus? A systematic review and meta-analysis of case-control studies.

Authors:  Hamidreza Majidiani; Sahar Dalvand; Ahmad Daryani; Ma de la Luz Galvan-Ramirez; Masoud Foroutan-Rad
Journal:  Braz J Infect Dis       Date:  2016-10-18       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.